Allogenic vaccine that contains a costimulatory polypeptide-expressing tumor cell
CA 2466530 A1 · Owner: Moebius, Ulrich · Inventors: Moebius, Ulrich; Sartorius, Ute; Breidenstein, Claudia
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of a tumor cell for producing a vaccine for the treatment or prophylaxis of tumors in patients said tumor cell expressing , a costimulatory polypeptide and said tumor cell and said patient having nonidentical MHC molecules. The invention further relates to the use of a costimulatory polypeptide-expressing tumor cell for producing a vaccine for increasing the lytic activity of NK cells in the treatment or prophylaxis of a tumor in a patient that is allogenic with respect to the tumor cell.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 8, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 8, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 8, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.